Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1998-04-01 (28 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MILLY-LA-FORET (91490), Essonne
PHARMACIE VALERIE MECHIN : revenue, balance sheet and financial ratios
PHARMACIE VALERIE MECHIN is a French company
founded 28 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MILLY-LA-FORET (91490),
this company of category PME
shows in 2025 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE VALERIE MECHIN (SIREN 418438677)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
3 200 803 €
3 451 448 €
3 428 433 €
2 797 218 €
2 655 213 €
2 712 728 €
2 687 249 €
2 713 793 €
2 718 186 €
Net income
49 796 €
121 532 €
133 154 €
122 239 €
89 971 €
78 715 €
115 197 €
223 051 €
90 761 €
EBITDA
64 798 €
72 133 €
106 873 €
117 956 €
92 925 €
87 634 €
142 883 €
143 580 €
169 898 €
Net margin
1.6%
3.5%
3.9%
4.4%
3.4%
2.9%
4.3%
8.2%
3.3%
Revenue and income statement
In 2025, PHARMACIE VALERIE MECHIN achieves revenue of 3.2 M€. Revenue is growing positively over 9 years (CAGR: +2.1%). Slight decline of -7% vs 2024. After deducting consumption (2.4 M€), gross margin stands at 769 k€, i.e. a rate of 24%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 65 k€, representing 2.0% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 50 k€, i.e. 1.6% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2025)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
3 200 803 €
Gross margin (2025)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
769 480 €
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
64 798 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
59 017 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
49 796 €
EBITDA margin (2025)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
2.0%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.9 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 2.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.738%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.178%
Cash flow / Revenue (2025)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
2.104%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
3.869
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
46.516
36.405
30.292
22.454
18.347
13.044
9.913
10.87
10.738
Financial autonomy
60.637
65.179
68.437
72.806
75.085
77.809
80.065
77.574
81.178
Repayment capacity
6.392
7.757
5.961
8.401
6.564
3.943
3.663
5.525
3.869
Cash flow / Revenue
4.693%
3.366%
3.841%
2.049%
2.252%
2.64%
1.843%
1.383%
2.104%
Sector positioning
Debt ratio
10.742025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of PHARMACIE VALERIE MECHIN (10.74) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.18%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE VALERIE MECHIN (81.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
3.87 years2025
2023
2024
2025
Q1: 0.51 years
Med: 2.46 years
Q3: 6.17 years
Average+9 pts over 3 years
In 2025, the repayment capacity of PHARMACIE VALERIE MECHIN (3.87) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 371.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 22.1x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
371.684
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
164.059
306.2
318.256
301.329
295.319
279.18
295.685
286.393
371.684
Interest coverage
9.812
7.413
7.547
8.809
5.933
3.717
7.91
19.137
22.12
Sector positioning
Liquidity ratio
371.682025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of PHARMACIE VALERIE MECHIN (371.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
22.12x2025
2023
2024
2025
Q1: 0.0x
Med: 1.91x
Q3: 5.98x
Excellent
In 2025, the interest coverage of PHARMACIE VALERIE MECHIN (22.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 28 days. Favorable situation: supplier credit is longer than customer credit by 26 days. Inventory turnover is 26 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 106 days of revenue, i.e. 940 k€ to permanently finance. Over 2017-2025, WCR increased by +160%, requiring additional financing.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
940 364 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
2 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
28 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
26 j
WCR in days of revenue (2025)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
106 j
WCR and payment terms evolution PHARMACIE VALERIE MECHIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
361 410 €
863 909 €
830 951 €
781 862 €
792 342 €
758 354 €
793 134 €
908 110 €
940 364 €
Inventory turnover (days)
27
29
28
28
36
30
24
27
26
Customer payment term (days)
7
9
7
4
4
3
2
3
2
Supplier payment term (days)
39
43
41
42
38
41
35
45
28
Positioning of PHARMACIE VALERIE MECHIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE VALERIE MECHIN is estimated at
991 037 €
(range 662 785€ - 1 284 491€).
With an EBITDA of 64 798€, the sector multiple of 7.7x is applied.
The price/revenue ratio is 0.61x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
662k€991k€1284k€
991 037 €Range: 662 785€ - 1 284 491€
NAF 5 année 2025
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
64 798 €×7.7x
Estimation500 260 €
252 279€ - 728 275€
Revenue Multiple30%
3 200 803 €×0.61x
Estimation1 942 349 €
1 430 961€ - 2 240 374€
Net Income Multiple20%
49 796 €×15.9x
Estimation791 015 €
536 787€ - 1 241 212€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE VALERIE MECHIN with other companies in the same sector:
Frequently asked questions about PHARMACIE VALERIE MECHIN
What is the revenue of PHARMACIE VALERIE MECHIN ?
The revenue of PHARMACIE VALERIE MECHIN in 2025 is 3.2 M€.
Is PHARMACIE VALERIE MECHIN profitable?
Yes, PHARMACIE VALERIE MECHIN generated a net profit of 50 k€ in 2025.
Where is the headquarters of PHARMACIE VALERIE MECHIN ?
The headquarters of PHARMACIE VALERIE MECHIN is located in MILLY-LA-FORET (91490), in the department Essonne.
Where to find the tax return of PHARMACIE VALERIE MECHIN ?
The tax return of PHARMACIE VALERIE MECHIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE VALERIE MECHIN operate?
PHARMACIE VALERIE MECHIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart